The 10% mindset and power of bold ideas | Prof. Dr. Dominik Ruettinger, Global Head R&D oncology, Bayer Pharmaceuticals
A conversation with Dr. Dominik Ruettinger, Global Head R&D oncology, Bayer Pharmaceuticals
This is Signal. The new voice for next generation biotech leaders, presented by Nucleate.
Get the email newsletter and unlock access to members-only content and updates
Processing your application
Please check your inbox and click the link to confirm your subscription.
There was an error sending the email
Get started with our best stories
Built from Within: How Local Capital Shapes Global Biotech Hubs
Biotech may be global in ambition, but ecosystems thrive when capital arrives and stays.
Reinventing R&D: collaborating for tomorrow’s therapies | Dr. Uli Stilz, Bio Innovation Hub at Novo Nordisk
A conversation with Dr. Uli Stilz, Head of Bio Innovation Hub at Novo Nordisk.
Breaking Barriers in Women's Health: The Vagina Business
A conversation with Dr. Marina Gerner, journalist and author of The Vagina Business
Ecosystems of Innovation: Finding Entrepreneurial Academics in the US
Explore how to identify entrepreneurial academics in biotech using key metrics like startup leadership, patents, and research grants.
Biotech journalism & scaling new heights for a good cause
A conversation with Luke Timmerman, award-winning biotech journalist and founder of the Timmerman Report.
Navigating the Biotech VC Landscape in Chicago
This report highlights the leading biotechnology venture capitalists in the Chicagoland area and provides an overview of its biotech investment landscape.
Biotech Venture Capital Activity in Brazil
Brazilian VC funding in biotech is on the rise, with approximately 50 firms investing in a diverse range of biotech sectors.
Enter the World of Hidden Layers
Introduction to the Nucleate Biotech Ecosystem Insights Series.
Introducing Signal
The human story of biotechnology, and how it will change life as we know it.
The 10% mindset and power of bold ideas | Prof. Dr. Dominik Ruettinger, Global Head R&D oncology, Bayer Pharmaceuticals
A conversation with Dr. Dominik Ruettinger, Global Head R&D oncology, Bayer Pharmaceuticals
Startups are hard, do something that matters | Armand Cognetta, CEO & Founder General Proximity
A conversation with Armand Cognetta, CEO & founder of General Proximity
Built from Within: How Local Capital Shapes Global Biotech Hubs
Biotech may be global in ambition, but ecosystems thrive when capital arrives and stays.
From science to startup: real talk on biotech founding paths | Hilary Schultz and Dr. William Heath, Persephoni BioPartners
A conversation with Hilary Schultz and Dr. William Heath, CEO and CSO at Persephoni BioPartners
Funding the Future: LA and Paris Biotech Ecosystem Insights
Written by Liz Hughes, Gohta Aihara, Clara Brouaux, Kenza Mourji, Maggie Wang, & Lauren Stanwicks About This Article This article is part of Nucleate’s Global Life Sciences series and accompanies our recent event “Los Angeles × Paris: Life Sciences Across Continents”, which brought together leaders from two rising biotech ecosystems....
Breakthrough: The stories behind Life-Changing Therapies | Dr. William Pao, former CDO of Pfizer
A conversation with Dr. William Pao, former CDO of Pfizer
Recommended
